官方服务：
资源简介：
CaSR modulator in neuroblastoma model [mouse]
应用场景：
创建时间：
2016-03-30
相关数据集
Synthesis and Preclinical Validation of Novel Indole Derivatives as a GPR17 Agonist for Glioblastoma Treatment
The discovery of a potential ligand-targeting G protein-coupled receptor 17 (GPR17) is important for developing chemotherapeutic agents against glioblastoma multiforme (GBM). We used the integration o
Figshare2021-07-26 更新80
High-throughput 3D glioblastoma model for rapid personalized therapeutic screening
Glioblastoma (GBM) is a devastating brain tumor with limited therapeutic success, largely due to the inability to pre-test patient-specific responses to treatment in a reliable and timely manner with
NIAID Data Ecosystem40
DataSheet1_Cinobufagin Is a Selective Anti-Cancer Agent against Tumors with EGFR Amplification and PTEN Deletion.PDF
Glioblastoma multiforme (GBM) is the most common and malignant brain tumor, and almost half of the patients carrying EGFR-driven tumor with PTEN deficiency are resistant to EGFR-targeted therapy. EGFR
NIAID Data Ecosystem20
NEW CHALCONE COMPOUND EXHIBITS MICRORNA-MEDIATED ANTICANCER PROPERTIES IN GLIOBLASTOMA
This study sought to investigate the therapeutic efficacy of a new synthetic chalcone molecule, SHG-44, its cellular mechanistic actions, alongside its effects on the miRNome in U87MG and U251 gliobla
Mendeley Data70
Glioblastoma tumorspheres treated with perphenazine (PER) and temozolomide (TMZ). Glioblastoma tumorspheres treated with perphenazine (PER) and temozolomide (TMZ)
Glioblastoma (GBM), a primary malignant brain tumor, has a poor prognosis, even with standard treatments such as radiotherapy and chemotherapy. In this study, we explored the anticancer effects of the
NIAID Data Ecosystem20
